CD8A and neoplasm: Our findings suggest that rBCG amplifies this effect, as evidenced by the greater prevalence of IFN-γ+ and TNF-α+ CD8+ T cells in both the spleen and tumor microenvironment, highlighting the potential to drive more effective and sustained antitumor immune responses.